Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, Version 1.5, on Clinical Laboratory Operations
Germer, Jeffrey J., Bendel, Jordan L., Dolenc, Craig A., Nelson, Sarah R., Masters, Amanda , Gerads, Tara M., Mandrekar, Jayawant N. , Mitchell, P. Shawn, Yao, Joseph D.

Mayo Clinic

Journal of Clinical Microbiology | July 19, 2007 | Volume: 45 | Issue: 9 | Pages: 3101-3104

10.1128/jcm.00656-07 | PMID 17634308 Get It

ABSTRACT The COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5 (CAP/CA), and the COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, were compared. CAP/CA reduced and consolidated labor while modestly increasing assay throughput without increased failure rates or direct costs, regardless of batch size and assay format.
Genetics of Carney Triad: Recurrent Losses at Chromosome 1 but Lack of Germline Mutations in Genes Associated with Paragangliomas and Gastrointestinal Stromal Tumors
Matyakhina, Ludmila, Bei, Thalia, McWhinney, Sarah R., Pasini, Barbara , Gunawan, Bastian, Stergiopoulos, Sotirios, Boikos, Sosipatros A. , Muchow, Michael , Dutra, Amalia, Pak, Evgenia, Campo, Elı́as , Cid, María C. , Gómez, Fulgencio , Gaillard, Rolf C., Assié, Guillaume , Füzesi, L., Baysal, Bora E. , Eng, Charis , Carney, J. Aidan, Stratakis, Constantine A. , Cameron, Silke , Campo, Elías , Stratakis, Constantine A , Eng, Charis , Pasini, Barbara

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 29, 2007 | Volume: 92 | Issue: 8 | Pages: 2938-2943

10.1210/jc.2007-0797 | PMID 17535989 Get It

Human Immunodeficiency Virus Type 1 Protease Cleaves Procaspase 8 In Vivo
Nie, Zilin , Bren, Gary D., Vlahakis, Stacey R., Schimnich, Alicia Algeciras, Brenchley, Jason M. , Trushin, Sergey A., Warren, Sarah , Schnepple, David, Kovacs, Colin , Loutfy, Mona , Douek, Daniel C. , Badley, Andrew D. , Badley, Andrew D

Mayo Clinic

Journal of Virology | April 19, 2007 | Volume: 81 | Issue: 13 | Pages: 6947-6956

10.1128/jvi.02798-06 | PMID 17442709 Get It

ABSTRACT Human immunodeficiency virus type 1 (HIV-1) infection causes apoptosis of infected CD4 T cells as well as uninfected (bystander) CD4 and CD8 T cells. It remains unknown what signals cause infected cells to die. We demonstrate that HIV-1 protease specifically cleaves procaspase 8 to create a novel fragment termed casp8p41, which independently induces apoptosis. casp8p41 is specific to HIV-1 protease-induced death but not other caspase 8-dependent death stimuli. In HIV-1-infected patients, casp8p41 is detected only in CD4 + T cells, predominantly in the CD27 + memory subset, its presence increases with increasing viral load, and it colocalizes with both infected and apoptotic cells. These data indicate that casp8p41 independently induces apoptosis and is a specific product of HIV-1 protease which may contribute to death of HIV-1-infected cells.
Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects.
Persson, M., Ford, G. C., Nair, K. S., Meek, Sarah

Mayo Clinic

Diabetes | March 6, 2007 | Volume: 47 | Issue: 12 | Pages: 1824-1835

10.2337/diabetes.47.12.1824 | PMID 9836512 Get It

To define the mechanism of insulin's anticatabolic action, the effects of three different dosages of insulin (0.25, 0.5, and 1.0 mU x kg(-1) x min(-1)) versus saline on protein dynamics across splanchnic and skeletal muscle (leg) beds were determined using stable isotopes of phenylalanine, tyrosine, and leucine in 24 healthy subjects. After an overnight fast, protein breakdown in muscle exceeded protein synthesis, causing a net release of amino acids from muscle bed, while in the splanchnic bed protein synthesis exceeded protein breakdown, resulting in a net uptake of these amino acids. Insulin decreased (P < 0.003) muscle protein breakdown in a dose-dependent manner with no effect on muscle protein synthesis, thus decreasing the net amino acid release from the muscle bed. In contrast, insulin decreased protein synthesis (P < 0.03) in the splanchnic region with no effect on protein breakdown, thereby decreasing the net uptake of the amino acids. In addition, insulin also decreased (P < 0.001) leucine nitrogen flux substantially more than leucine carbon flux, indicating increased leucine transamination (an important biochemical process for nitrogen transfer between amino acids and across the organs), in a dose-dependent manner, with the magnitude of effect being greater on skeletal muscle than on the splanchnic bed. In conclusion, muscle is in a catabolic state in human subjects after an overnight fast and provides amino acids for synthesis of essential proteins in the splanchnic bed. Insulin achieves amino acid balance across splanchnic and skeletal muscle beds through its differential effects on protein dynamics in these tissue beds.
Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease
Xu, Yanhui , Flies, Andrew S. , Flies, Dallas B. , Zhu, Gefeng, Anand, Sudarshan , Flies, Sarah J., Xu, Haiying, Hancock, Wayne W. , Tamada, Koji , Anders, Robert A. , Chen, Lieping

Mayo Clinic

Blood | December 19, 2006 | Volume: 109 | Issue: 9 | Pages: 4097-4104

10.1182/blood-2006-09-047332 | PMID 17179227 Get It

Abstract Decoy lymphotoxin β receptor (LTβR) has potent immune inhibitory activities and thus represents a promising biologic for the treatment of inflammation, autoimmune diseases, and graft-versus-host disease (GVHD). As this reagent interrupts multiple molecular interactions, including LTβ-LTβR and LIGHT-HVEM/LTβR, underlying molecular mechanisms have yet to be fully understood. In this study, we demonstrate that blockade of the LIGHT-HVEM pathway is sufficient to induce amelioration of GVHD in mouse models. Anti–host cytotoxic T lymphocyte (CTL) activity following in vivo transfer of allogeneic lymphocytes was completely abrogated when LIGHT- or HVEM-deficient (KO) T cells were used as donor cells. Accordingly, survival of the recipient mice following the transfer of allogeneic bone marrow cells plus LIGHT-KO or HVEM-KO T cells was significantly prolonged. In the absence of LIGHT-HVEM costimulation, alloreactive donor T cells undergo vigorous apoptosis while their proliferative potential remains intact. Furthermore, we prepared a neutralizing monoclonal antibody (mAb) specific to HVEM and showed that administration of anti–HVEM mAb profoundly ameliorated GVHD and led to complete hematopoietic chimerism with donor cells. Collectively, our results demonstrate an indispensable role of LIGHT-HVEM costimulation in the pathogenesis of GVHD and illustrate a novel target for selective immunotherapy in allogeneic bone marrow transplantation.
Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity
Klos, Kevin J., Ahlskog, J. Eric , Kumar, Neeraj , Cambern, Sarah J, Butz, James J. , Mf, Burritt, Fealey, Robert D., Cowl, Clayton T. , Parisi, J. E., Josephs, Keith A.

Mayo Clinic

Neurology | December 13, 2006 | Volume: 67 | Issue: 11 | Pages: 1984-1989

10.1212/01.wnl.0000247037.37807.76 | PMID 17159105 Get It

Screening for prevention of optic nerve damage due to chronic open angle glaucoma
Hatt, Sarah R. , Wormald, Richard , Burr, Jennifer

Mayo Clinic

Cochrane Database of Systematic Reviews | October 20, 2006 | Volume: 2010 | Issue: 1 | Pages: No page available

10.1002/14651858.cd006129.pub2 | PMID 17054274 Get It

Prospective Evaluation of Clonal Evolution During Long-Term Follow-Up of Patients With Untreated Early-Stage Chronic Lymphocytic Leukemia
Fink, Stephanie, Jenkins, Robert B. , Paternoster, Sarah F., Smoley, Stephanie A., Stockero, Kimberly J., Nast, Danielle M., Flynn, Heather C., Tschumper, Renee C. , Geyer, Susan M. , Call, Tim G., Jelinek, Diane F., Dewald, Gordon W., Shanafelt, Tait D. , Witzig, Thomas E. , Zent, Clive S. , Call, Timothy G., Kay, Neil E.

Mayo Clinic

Journal of Clinical Oncology | September 28, 2006 | Volume: 24 | Issue: 28 | Pages: 4634-4641

10.1200/jco.2006.06.9492 | PMID 17008705 Get It

Purpose Retrospective studies suggest cytogenetic abnormalities detected by interphase fluorescent in situ hybridization (FISH) can identify patients with chronic lymphocytic leukemia (CLL) who will experience a more aggressive disease course. Other studies suggest that patients may acquire chromosome abnormalities during the course of their disease. There are minimal prospective data on the clinical utility of the widely used hierarchical FISH prognostic categories in patients with newly diagnosed early-stage CLL or the frequency of clonal evolution as determined by interphase FISH. Patients and Methods Between 1994 and 2002, we enrolled 159 patients with previously untreated CLL (83% Rai stage 0/I) on a prospective trial evaluating clonal evolution by FISH. Patients provided baseline and follow-up specimens for FISH testing during 2 to 12 years. Results Chromosomal abnormalities detected by FISH at study entry predicted overall survival. Eighteen patients experienced clonal evolution during follow-up. The rate of clonal evolution increased with duration of follow-up with only one occurrence in the first 2 years (n = 71; 1.4%) but 17 occurrences (n = 63; 27%) among patients tested after 5+ years. Clonal evolution occurred among 10% of ZAP-70–negative and 42% of ZAP-70–positive patients at 5+ years (P = .008). Conclusion This clinical trial confirms prospectively that cytogenetic abnormalities detected by FISH can predict overall survival for CLL patients at the time of diagnosis, but also suggests that many patients acquire new abnormalities during the course of their disease. Patients with higher ZAP-70 expression may be more likely to experience such clonal evolution. These findings have important implications for both clinical management and trials of early treatment for patients with high-risk, early-stage CLL.
Cognitive impairment in hemodialysis patients is common
Murray, Anne M. , Tupper, David E., Gilbertson, David T. , Pederson, Sarah, Li, Shuting , Smith, Glenn E. , Hochhalter, Angela K., Collins, A.J., Kane, Robert L , Knopman, David S.

Mayo Clinic

Neurology | July 24, 2006 | Volume: 67 | Issue: 2 | Pages: 216-223

10.1212/01.wnl.0000225182.15532.40 | PMID 16864811 Get It

Surgical interventions for bilateral congenital cataract
Long, Vernon, Chen, Sean , Hatt, Sarah R.

Mayo Clinic

Cochrane Database of Systematic Reviews | July 18, 2006 | Volume: 2008 | Issue: 4 | Pages: No page available

10.1002/14651858.cd003171.pub2 | PMID 16855998 Get It